Inventor · disambiguated record
Gene Timothy Fass
Also filed as: FASS GENE TIMOTHY
8 granted patents·25 citations·filing 2013–2023
83Inventor score
Top patents by PatentIndex Score
8 records- 0194US11702415B2Crystalline hydrate of a JAK inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Jul 18, 2023·6 cites·22 claims
- 0293US10844057B2Process for preparing JAK inhibitors and intermediates thereofTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Nov 24, 2020·11 cites·21 claims
- 0389US11718591B2Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereofTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Aug 8, 2023·1 cites·20 claims
- 0487US10100021B2Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereofTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Oct 16, 2018·4 cites·24 claims
- 0586US10752599B2Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereofTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Aug 25, 2020·3 cites·20 claims
- 0679US11718616B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Aug 8, 2023·0 cites·7 claims
- 0772US12122773B2Crystalline hydrate of a JAK inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Oct 22, 2024·0 cites·19 claims
- 0860US8889882B2Process for preparing biphenyl imidazole compoundsZHANG WEIJIANG·Filed 2013·Granted Nov 18, 2014·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →